Cargando…
Fondaparinux: A cornerstone drug in acute coronary syndromes
In acute coronary syndrome (ACS), the use of anticoagulants in conjunction with antiplatelet agents in the acute phase has resulted in reduced ischemic events and is more effective than either class of drug used alone. Though parenteral anticoagulation is essential at the time of diagnosis, a balanc...
Autores principales: | Khan, Mohammed Yunus, Ponde, Chandrashekhar K, Kumar, Viveka, Gaurav, Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788176/ https://www.ncbi.nlm.nih.gov/pubmed/35126871 http://dx.doi.org/10.4330/wjc.v14.i1.40 |
Ejemplares similares
-
Evaluation of Effectiveness and Tolerability of Fondaparinux in the Management of Symptomatic Acute Coronary Syndrome: A Real-World Evidence-Based Study on an Indian Population
por: Dalal, Jamshed, et al.
Publicado: (2022) -
Management of acute coronary syndromes with fondaparinux
por: Wienbergen, Harm, et al.
Publicado: (2007) -
Rifabutin as salvage therapy for Helicobacter pylori eradication: Cornerstones and novelties
por: Borraccino, Antonia Valeria, et al.
Publicado: (2022) -
Generalizable items of quantitative and qualitative cornerstones for personnel requirement of physicians in anesthesia
por: Weiss, Manfred, et al.
Publicado: (2017) -
Insulin resistance and adipose tissue interactions as the cornerstone of metabolic (dysfunction)-associated fatty liver disease pathogenesis
por: Pal, Shreya C, et al.
Publicado: (2023)